跳至主要内容
临床试验/NCT00189124
NCT00189124已完成2 期

Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?

University of Michigan2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2003年9月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
13
试验地点
2
主要终点
Brachial artery reactivity, by flow mediated dilatation

研究概览

简要总结

The purpose of this study is to evaluate the effect of DHEA on endothelial dysfunction in patients with systemic lupus by measuring:

  1. changes in brachial artery flow-mediated dilatation (FMD) and
  2. changes in biomarkers of cardiovascular risk. Patients will be enrolled in a randomized, double-blinded crossover trial of DHEA or placebo for ten weeks, then crossed over to the alternate treatment arm after a six-week washout period.

HYPOTHESIS: Dehydroepiandrosterone (DHEA) administration in premenopausal women with SLE modifies cardiovascular risk by improving vascular endothelial function and other biomarkers associated with cardiovascular heart disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Member of the Michigan Lupus Cohort
  • Meet the American College of Rheumatology (ACR) criteria for SLE
  • Premenopausal

排除标准

  • Prednisone dose > 10 mg

结局指标

主要结局

Brachial artery reactivity, by flow mediated dilatation

次要结局

  • Changes in biomarkers of SLE
  • Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wendy Marder

Associate Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验